Drug Shortage Report for AURO-OLMESARTAN HCTZ
Report ID | 108673 |
Drug Identification Number | 02476495 |
Brand name | AURO-OLMESARTAN HCTZ |
Common or Proper name | Hydrochlorothiazide; Olmesartan Medoxil |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
Strength(s) | 12.5MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30's |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-12 |
Estimated end date | 2024-07-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-06-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2023-07-21 | English | Compare |
v15 | 2023-07-21 | English | Compare |
v14 | 2021-03-25 | French | Compare |
v13 | 2021-03-25 | English | Compare |
v12 | 2021-02-12 | French | Compare |
v11 | 2021-02-12 | English | Compare |
v10 | 2021-02-03 | French | Compare |
v9 | 2021-02-03 | English | Compare |
v8 | 2021-01-08 | French | Compare |
v7 | 2021-01-08 | English | Compare |
v6 | 2020-11-24 | French | Compare |
v5 | 2020-11-24 | English | Compare |
v4 | 2020-09-11 | French | Compare |
v3 | 2020-09-11 | English | Compare |
v2 | 2020-03-13 | French | Compare |
v1 | 2020-03-13 | English | Compare |